Desfrançois et al. discovered that T cells which have a double-positive CD4 and CD8 profile are identified in almost 60% of melanomas and encompass an original cytokine repertoire, characterized by significant secretion of interleukins 4, 5, and 13 [35]. Here, CD4 is linked to melanoma.